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Abstract
Background: Hirschsprung’s disease (HSCR) is a classic oligogenic disorder. Except inactivating mutations of RET,
some single nucleotide polymorphisms (SNPs) are identified to be associated with the risk of HSCR. This study was
conducted to examine the impact of the haplotypes profile of the reported associated SNPs of RET on the risk of
HSCR in a Southeastern Chinese population.
Methods: Genotypes of -5G > A (rs10900296), -1A > C (rs10900297), c135G > A (rs1800858), c1296A > G
(rs1800860), and c2307T > G (rs1800861) were analyzed in 123 HSCR patients and 168 controls by polymerase
chain reaction amplification and direct sequencing. Associations with risk of HSCR were estimated by odds ratio
(OR) and their 95% confidence intervals (95% CI) using logistic regression.
Results: We observed a significantly increased risk of HSCR associated with the RET -5AA (OR = 17.75, 95% CI =
7.34-42.92), -1CC (OR = 10.89, 95% CI = 3.13-37.85), 135AA (OR = 13.61, 95% CI = 6.14-30.14), 1296GG (OR = 2.40,
95% CI = 1.38-4.18) or 2307GG (OR = 9.79, 95% CI = 4.28-22.43) respectively. The five SNPs were in strong linkage
disequilibrium. The haplotype A-C-A-G-G (OR = 5.06, 95% CI = 1.97-12.99) and diplotype A-C-A-G-G/A-C-A-G-G (OR
= 21.08, 95% CI = 5.28-84.09) was also associated with the increased risk of HSCR, indicating a cumulative effect of
these SNPs on the susceptibility of HSCR.
Conclusion: These results support the hypothesis that common variations in RET pathway might play an important
role in development of HSCR.
Background
Hirschsprung’s disease (HSCR) is a congenital disorder
characterized by the absence of enteric ganglion cells in
the myenteric (Auerbach’s) and submucosal (Meissner’s)
plexuses of the variable lengths of gastrointestinal tract.
The lack of enteric neurons is attributed to the defective
proliferation, differentiation, survival, and migration of
enteric nervous system (ENS) towards the end of the
gut, whereby neural crest cells (NCC) fail to innervate
the lower gastrointestinal tract during embryonic
development, presenting in clinic with failure to pass
meconium, bilious vomiting, enterocolitis-associated
diarrhoea, chronic severe constipation and progressive
abdominal distension in the neonatal period [1,2]. Based
on the length of the aganglionic segment, it can be clas-
sified into three subgroups: short-segment aganglionosis
(S-HSCR), long-segment aganglionosis (L-HSCR), and
total colonic aganglionsis (TCA). Noteworthy, there is
significant racial variation in the incidence of the disease
worldwide, which is most prevalent in Asians, including
China, about 2.8 per 10,000 live births. The male to
female ration (M:F) is around 4:1 among S-HSCR
patients and 1:1 among L-HSCR patients. Generally,
HSCR most commonly presents sporadically although it
can be familial and manifests with low, sex-dependent
penetrance and phenotypic variability [2].
HSCR is a heterogenic disorder with a number of
genes reported to be associated, most of which involved
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development. RET, a receptor tyrosine kinase, is the
major susceptibility gene for HSCR, which locates in
10q11.2 and encodes a transmembrane tyrosine kinase
receptor, responsible for triggering a number of down-
stream signaling transductions [3-5]. There is growing
evidence showing that some potentially functional single
nucleotide polymorphisms (SNPs) of RET gene could
act as low susceptibility factors and modify the pheno-
type of HSCR, especially in certain combinations
of alleles, haplotypes. Specifically, three common
SNPs in the coding region of RET, c135G > A in exon2
(rs1800858, A45A), c1296A > G (rs1800860, A432A) in
exon7 and c2307T > G (rs1800861, L769L) in exon13,
were firstly reported to be associated with HSCR [6-8].
Two promoter polymorphisms -5G > A and -1A > C
(rs10900296 and rs10900297) were also reported to be
strongly associated with HSCR and have a significantly
lower activity in an in vitro dual-luciferase expression
assay conducted by Fitze G and his colleagues [2,9].
Garcia-Barceló, et al [10] further demonstrated that
these two SNPs may disrupt a transcriptional factor,
TTF1, binding site and then reduce transcription capa-
city from the promoter. However, to our best knowl-
edge, looking at these 5 particular SNPs all at once in
haplotype profile in the Chinese Han population and
their effects on the risk of HSCR have not been fully
described.
In this study, we conducted a large case-control study
to evaluate the contribution of the genotypes and haplo-
types of these aforementioned five SNPs in the patho-
genesis of sporadic HSCR in a Southeastern Chinese
population.
Methods
Study subjects
This case-control study consisted of 123 sporadic
HSCR (males: 75.6%) and 194 controls (males: 73.7%).
Cases were histological diagnosed with either biopsy or
surgical resection material for absence of enteric
plexuses in Children’s Hospital Affiliated to Zhejiang
University Medical School, among which twelve (10%)
of patients were affected with long-segment aganglio-
nosis (LSA) and the rest with short-segment aganglio-
nosis (SSA). Controls were normal children taking
physical examination in the same hospital during the
same time period as the patients were enrolled and fre-
quency matched to cases by sex and age. Both cases
and controls were Chinese Han in Zhejiang and
informed consent was obtained from their parents. The
study was approved by the Institutional Review Board
of the Children’s Hospital Affiliated to Zhejiang Uni-
versity Medical School.
Polymorphism Analysis
Genomic DNA was extracted from blood sample of all
study subjects by using QIAamp-Blood Kit (Qiagen, Hil-
den, Germany). Genotypes were determined by PCR and
direct sequencing without knowledge of the subjects’
case/control status. Fifteen percent of the masked sam-
ple was randomly selected and genotyped twice by dif-
ferent people independently. The reproducibility was
100%.
RET SNPs (-5G > A, -1A > C, c135G > A, c1296A > G,
and c2307T > G) were genotyped as described previously
[6,11,12]. PCR primers for RET -5G > A and -1A >
Cw e r e5 ’-CCCGCACTGAGCTCCTAC-3’ and 5’-GG
ACGTCGCCTTCGCCAT-3’,a n d5 ’-TCT CGAGG-
GATGCTTACTGG-3’ and 5’-GGCTCCGGTTAAGGTA-
GAGG-3’ for c135G > A, 5’-CCCTGGTGGGGCATTT
GTGC-3’ and 5’-GGGTGGTTGGAAACTGATGG-3’ for
c1296 A > G and 5’-GAACTTGGGCAAGGCGATGC-3’
and 5’-ACCCTGCAGCTGGCCTTAC-3’ for c2307T > G,
respectively. Amplication of the fragments was accom-
plished under a 25-ul reaction mixture with ~100 ng
template DNA, 0.5 uM each primer, 0.2 mM each dNTP,
2.0 mM MgCl2 and 1.0 units of Tag DNA polymerase
with 1 × reaction buffer (Applied Biosystems, Foster City,
CA). The PCR profile consisted of an initial melting step
of 5 minutes at 95°C, followed by 35 cycles of 40 seconds
at 95°C, 30 seconds at 63°C (57°C for c135G > A and
c2307T > G), and 45 second at 72°C, and a final elonga-
tion step of 7 minutes at 72°C. PCR products were then
sequenced using an ABI PRISM
® Big Dye™ Terminator
v3.1 Cycle sequencing kit (Applied Biosystems, Foster
City, CA) and an ABI 3130 automated sequencer accord-
ing to the manufacturer’s instructions.
Statistical analysis
Chi-square test was used to compare the allele and gen-
otype frequencies between cases and controls, as well as
LSA and SSA. The associations between the genotype
and the risk of HSCR were estimated by odds ratios
(ORs) and their 95% confidence interval (CI), which was
calculated by unconditional logistic regression adjusted
for gender. PHASE v2.1 [13] was used to estimate the
haplotype frequencies composed of five SNP pairs,
respectively, and their difference between patients and
controls. Diplotype were defined by two haplotypes of
each individual. Bonferroni adjustment was used to
adjust multiple comparison and p values were consid-
ered significantly at a level of 0.003, to allow for the
testing of 5 partially correlated markers using 3 different
inheritance model (dominant, recessive, and additive
model). All of the statistical analyses were performed
using Statistical Analysis System software (version 9.12;
SAS Institute, Cary, NC).
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Association of RET SNPs with the risk of HSCR
All the five markers in the controls conformed to HWE
(P > 0.05, data not shown). The frequency of A allele
in -5G > A, C allele in -1A > C, A allele in 135G > A, G
allele in 1296A > G and G allele in 2307T > G in cases
were 82.5%, 88.6%, 78.9%, 90.7% and 82.1%, which was
higher than that of 45.5%, 63.1%, 43.8%, 80.4% and 49.7%
in controls, with the P for Cochran-Armitage trend test
of 1.12 × 10
-16,3 . 4 3×1 0
-11,4 . 2 0×1 0
-15,5 . 7 0×1 0
-4,
and 2.32 × 10
-14, respectively. All those markers were
shown to be strongly associated with the HSCR risk
(Table 1). None of these SNPs were significantly different
between LSA and SSA patients (data not shown).
Unconditional logistic regression model was used to
estimate RET SNPs effect (additive, dominant, or reces-
sive) according to the smallest AIC (Akaike information
criteria) value. Subjects carrying the RET -5AA, -1CC,
135AA or 2307GG genotype had a 17.75-fold (95% CI =
7.34-42.92), 10.89-fold (95% CI = 3.13-37.85), 13.61-fold
(95% CI = 6.14-30.14) or 9.79-fold (95% CI = 4.28-
22.43) elevated risk for the development of HSCR, com-
pared with the counterpart wild genotype, respectively.
The much higher OR value in the present study and
previously published association studies indicated that
HSCR is a classic oligogenic disorder, which is different
from the common complex diseases, such as sporadic
cancers, cardiovascular diseases and type 2 diabetes with
OR less than 2,. Because the frequencies of wild geno-
type for 1296A > G were low, we combined it with het-
erozygous-type genotype together for analysis. Similarly,
the homozygous RET 1296GG genotype was also linked
to risk of HSCR, with the OR of 2.40 (95% CI = 1.38 -
4.18) compared with the AA or AG genotype.
RET haplotypes and risk of HSCR
We further analyzed the association of the haplotypes
(MAF > 0.05) comprising the five HSCR-associated
SNPs with HSCR risk. The haplotype and diplotype fre-
quencies are presented in Table 2 and LD analysis
showed that the 5 SNPs are part of the same haplotype
block in Chinese (D’ > 0.6). The haplotype A-C-A-G-G,
was highly associated with an increased risk of HSCR
(OR = 5.06, 95% CI = 1.97-12.99, P = 0.001). Intrigu-
ingly, the haplotype composited with more HSCR-risk
allele associated with more elevated risk of HSCR, indi-
cating there is a cumulative effect of these 5 SNPs on
the risk of HSCR (P =7 . 3 3×1 0
-17, for Cochran-Armi-
tage trend test). We also investigated the associations
between RET diplotypes and risk of HSCR. Since the
low frequencies of haplotype G-A-G-A-T and G-A-G-
G-T, we combined them as reference in the following
analysis. In consistent with the results from haplotype,
the genetic risk of HSCR was increased in subjects with
less copies of the G-A-G-A(G)-T haplotype and more
copies of the A-C-A-G-G haplotype, with the P values
for the Cochran-Armitage test of 3.09 × 10
-15.O n l y
diplotype with two copy of risk haplotype, A-C-A-G-G/
A-C-A-G-G, was found to be associated with increased
risk of HSCR (OR = 21.08, 95% CI = 5.28-84.09), when
compared with wild type of diplotype, suggesting a hap-
lotype-dosage effect in the genetic susceptibility of
HSCR.
Discussion
This genetic epidemiological study investigated whether
genetic polymorphisms in RET, alone or in combination,
could have effects on the risk of HSCR in a Southeastern
Chinese population. In this case-control study including
Table 1 Genotype distribution of the RET gene polymorphisms in case-control
Polymorphism Genotypes Controls n = 168 cases n = 123 OR
b (95% CI); P
-5G > A, rs10900296
a GG 50 (29.8) 7 (5.7) Reference
GA 83 (49.4) 29 (23.9) 2.50 (1.02-6.12); 0.046
AA 35 (20.8) 87 (67.4) 17.75 (7.34-42.92); < 0.001
-1A > C, rs10900297
b AA 22 (13.1) 3 (2.4) Reference
AC 80 (47.6) 22 (17.9) 2.02 (0.55-7.38); 0.288
CC 66 (39.3) 98 (79.7) 10.89 (3.13-37.85); < 0.001
c135G > A, rs1800858
c GG 52 (31.0) 10 (8.1) Reference
GA 85 (50.6) 32 (26.0) 1.95 (0.89-4.32); 0.095
AA 31 (18.4) 81 (65.9) 13.61 (6.14-30.14); < 0.001
C1296A > G, rs1800860
d AA 6 (3.6) 0 (0.0) Reference
AG 54 (32.1) 23 (18.7)
GG 108 (64.3) 100 (81.3) 2.40 (1.38-4.18); 0.002
c2307T > G, rs1800861
e TT 37 (22.0) 9 (7.3) Reference
TG 95 (56.6) 26 (21.1) 1.08 (0.46-2.53); 0.853
GG 36 (21.4) 88 (71.6) 9.79 (4.28-22.43); < 0.001
ap = 1.12 × 10
-16,
bp = 3.43 × 10
-11,
cp = 4.20 × 10
-15,
dp = 5.70 × 10
-4,
ep = 2.32 × 10
-14, for Cochran-Armitage trend test.
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matched controls, we demonstrated that five polymorph-
isms in RET gene, including two SNPs in the regulatory
region and three SNPs in the coding region, had substan-
tial impact on risk of HSCR, separately or collectively.
Subjects carrying the homozygous variant genotypes of
-5G > A, -1A > C, c135G > A, c1296A > G or c2307T >
G SNPs were at an increased risk for developing HSCR.
Moreover, we also observed cumulative effects of these
five polymorphisms on HSCR risk, demonstrating the
haplotype composited with more HSCR-risk alleles ren-
dered the hosts more susceptible to HSCR. To our best
knowledge, this is the first study to investigate the contri-
bution of the haplotypes of these five SNPs to the patho-
genesis of sporadic HSCR in Chinese population. It lends
supports to the previous findings that these SNPs were
associated with the risk of HSCR [1,2,7,10,14-16].
Liu CP et al. reported C135 G/A and C1296 A/G at
exon 2 and the combination of AG of these two SNPs
were associated with susceptibility of HSCR in Southeast
Chinese population [17,18]. Also, they observed these two
SNPs were in LD with two other coding SNPs at exon 14
and exon 15 in the same population. Our results expanded
their findings and found that C135G/A and C1296 A/G
were in LD with the two functional SNPs (-5G > A and
-1A > C) in the promoter region and C2307T > G in exon
13. Furthermore, we observed 54.4% of the cases but only
8.4% of the controls carried A-C-A-G-G/A-C-A-G-G
diplotype, with a more than 21-fold increased risk of
HSCR, indicating a cumulative effect of the A-C-A-G-G
combination on the susceptibility of HSCR and A-C-A-G-
G may represent the core of the susceptibility allele.
Intriguingly, we found that the frequencies of risk
alleles of-5G > A, -1A > C, c135G > A, c1296A > G or
c2307T > G in Chinese Han were much higher than
those in European [19], partially explaining the relatively
higher incidence of HSCR in Chinese. In conclusion, we
observed a strong association between a haplotype, com-
prising the 3 most common SNPs in coding region and
two in promoter region, and HSCR risk. These results
support the hypothesis that common variations in RET
pathway play an important role in pathogenesis of
HSCR and might provide clues to develop screening and
surveillance strategies.
Conclusion
These results support the hypothesis that common var-
iations in RET pathway might play an important role in
development of HSCR.
Acknowledgements
We would like to express our gratitude to all the subjects who participated
in the study, especially Xiaoping Miao for scientific editing this manuscript.
This work was supported by research grants from Program for New Century
Excellent Talents in University NCET-10-0388 and the Fundamental Research
Funds for the Central Universities 2010QN005.
Author details
1Department of Pediatric Surgery, Children’s Hospital Zhejiang University
School of Medicine, Hangzhou, PR China.
2Department of Epidemiology and
Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical
Sciences and Peking Union Medical College, Beijing, PR China.
3Department
of Epidemiology and Biostatistics and MOE Key Lab of Environment and
Health, School of Public Health, Tongji Medical College, Huazhong University
of Science and Technology, Wuhan, PR China.
4Department of
Otolaryngology, Capital Pediatric Institute, Beijing, PR China.
5Department of
Gastroenterology, Peking Union Medical College Hospital, Chinese Academy
of Medical Sciences, Beijing, PR China.
Table 2 Frequencies and counts of RET haplotypes and diplotypes comprising -5G > A, -1A > C, c135G > A, c1296A >
G and c2307T > G
Haplotypes
a Patients (246 chromosomes) Controls (336 chromosomes) OR
b (95% CI); P
(-5; -1; c135; c1296; c2307) % numbers % numbers
G-A-G-A-T 2.4 6 6.0 20 reference
b
G-A-G-G-T 8.1 20 25.3 85 0.78 (0.28-2.20);0.641
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